糖化血红蛋白诊断肾移植后糖尿病准确性的系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Embase和SCOPUS至2016年6月,纳入6项以口服葡萄糖耐量试验为参考标准的成人肾移植受者研究。HbA1c切点6.5%早期诊断移植后糖尿病的敏感度为0.48、特异度为0.96;切点6.2%的敏感度为0.76、特异度为0.89,提示高特异度但低至中等敏感度。
要点
- HbA1c 6.5%切点早期诊断PTDM敏感度0.48、特异度0.96。
- HbA1c 6.2%切点敏感度0.76、特异度0.89。
- 两个切点均表现为高特异度、低至中等敏感度。
核心结论
- HbA1c切点6.5%和6.2%诊断PTDM均呈现高特异度但低至中等敏感度。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Embase和SCOPUS至2016年6月。
- 纳入报告口服葡萄糖耐量试验为参考标准、采用标准化方法测定HbA1c且提供2×2表数据的成人无既往糖尿病研究。
- 采用双变量模型计算合并估计值。
主要发现
- 基于6项研究2057例肾移植受者,移植后早期HbA1c切点6.5%诊断PTDM的敏感度为0.48(95%CI 0.31-0.65),特异度为0.96(95%CI 0.95-0.97)。
- HbA1c切点6.5%的阳性似然比为12.0(95%CI 7.4-19.5),阴性似然比为0.54(95%CI 0.38-0.77)。
- 基于4项研究1888例肾移植受者,移植后早期HbA1c切点6.2%诊断PTDM的敏感度为0.76(95%CI 0.49-0.91),特异度为0.89(95%CI 0.86-0.92)。
- HbA1c切点6.2%的阳性似然比为7.18(95%CI 5.29-9.75),阴性似然比为0.27(95%CI 0.11-0.65)。
关键数值与推荐
- HbA1c切点6.5%:敏感度0.48(95%CI 0.31-0.65),特异度0.96(95%CI 0.95-0.97),PLR 12.0(95%CI 7.4-19.5),NLR 0.54(95%CI 0.38-0.77)。
- HbA1c切点6.2%:敏感度0.76(95%CI 0.49-0.91),特异度0.89(95%CI 0.86-0.92),PLR 7.18(95%CI 5.29-9.75),NLR 0.27(95%CI 0.11-0.65)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early detection of post-transplantation diabetes mellitus (PTDM) allows prompt clinical and pharmacological interventions, reducing the chance of adverse outcomes. We conducted a systematic review and meta-analysis to determine the overall diagnostic accuracy of glycated hemoglobin (HbA1c) for the diagnosis of renal PTDM. METHODS: We searched MEDLINE, Embase and SCOPUS up to June 2016. Studies that included adults without previous diabetes were selected if they reported an oral glucose tolerance test as a reference test, HbA1c levels measured by standardized methods and data necessary for drawing 2 × 2 tables. A bivariate model was used to calculate the pooled estimates. RESULTS: Based on 2057 kidney recipients from six studies, an HbA1c cut-off point of 6.5% in early months after transplant resulted in sensitivity of 0.48 [95% confidence interval (95% CI) 0.31-0.65], specificity of 0.96 (95% CI 0.95-0.97), positive likelihood ratio (PLR) of 12.0 (95% CI 7.4-19.5) and negative likelihood ratio (NLR) of 0.54 (95% CI 0.38-0.77). Based on 1888 kidney recipients from four studies, an HbA1c cut-off point of 6.2% early after transplant resulted in sensitivity of 0.76 (95% CI 0.49-0.91), specificity of 0.89 (95% CI 0.86-0.92), PLR of 7.18 (95% CI 5.29-9.75) and NLR of 0.27 (95% CI 0.11-0.65). CONCLUSION: HbA1c cut-off points of 6.5% and 6.2% presented high specificity but low/moderate sensitivity to diagnose PTDM.
引用
- Pimentel AL, Cavagnolli G, Camargo JL, et al. Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis. Nephrol Dial Transplant. 2017. PMID: 28088775. doi:10.1093/ndt/gfw437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。